Tag archive for ‘Can-Fite BioPharma Ltd. (TASE: CFBI) (OTCQB: CANFY)’
Jewish Business News Service On Sunday, November 17th, 2013

Israeli Can-Fite BioPharma Announces Approval of ADR Listing on NYSE MKT

– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013 under the ticker symbol “CANF”. – Israeli Can-Fite BioPharma More...

Jewish Business News Service On Wednesday, November 6th, 2013

CanFite Wins U.S. Patent For The Reduction Of Intraocular Pressure

– Can-Fite BioPharma Ltd. (TASE: CFBI), (OTCQB: CANFY) and its subsidiary, OphthaliX Inc. (OTCQB: OPLI), jointly announced today that the U.S. Patent and Trademark Office granted a U.S. patent More...

Wordpress site Developed by Fixing WordPress Problems